NO20024322D0 - Sekvens - Google Patents

Sekvens

Info

Publication number
NO20024322D0
NO20024322D0 NO20024322A NO20024322A NO20024322D0 NO 20024322 D0 NO20024322 D0 NO 20024322D0 NO 20024322 A NO20024322 A NO 20024322A NO 20024322 A NO20024322 A NO 20024322A NO 20024322 D0 NO20024322 D0 NO 20024322D0
Authority
NO
Norway
Prior art keywords
sequence
Prior art date
Application number
NO20024322A
Other languages
English (en)
Other versions
NO20024322L (no
NO333664B1 (no
Inventor
Nathalie Simard
Huub Brouwers
Simon Jones
Steven Griffiths
Pablo Valenzuela
Luis Burzio
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32931600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024322(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0005838.8A external-priority patent/GB0005838D0/en
Priority claimed from GBGB0016082.0A external-priority patent/GB0016082D0/en
Priority claimed from GBGB0016080.4A external-priority patent/GB0016080D0/en
Priority claimed from GBGB0018599.1A external-priority patent/GB0018599D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20024322L publication Critical patent/NO20024322L/no
Publication of NO20024322D0 publication Critical patent/NO20024322D0/no
Publication of NO333664B1 publication Critical patent/NO333664B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20024322A 2000-03-11 2002-09-10 Aminosyresekvens, nukleinsyresekvens fra HSP 70 antigenet til Piscirickettsia salmonis samt anvendelse av aminosyresekvens for vaksine- og kitfremstilling, vaksine og diagnostisk test-kit NO333664B1 (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB0005838.8A GB0005838D0 (en) 2000-03-11 2000-03-11 Sequence
GBGB0016082.0A GB0016082D0 (en) 2000-07-01 2000-07-01 Sequence 3
GBGB0016080.4A GB0016080D0 (en) 2000-07-01 2000-07-01 Sequence 2
GBGB0018599.1A GB0018599D0 (en) 2000-07-29 2000-07-29 Sequence 4
PCT/GB2001/001055 WO2001068865A2 (en) 2000-03-11 2001-03-12 Fish vaccine against piscirickettsia salmonis
CA2407301A CA2407301C (en) 2000-03-11 2002-09-18 Hsp60 sequence from piscirickettsia salmonis

Publications (3)

Publication Number Publication Date
NO20024322L NO20024322L (no) 2002-09-10
NO20024322D0 true NO20024322D0 (no) 2002-09-10
NO333664B1 NO333664B1 (no) 2013-08-05

Family

ID=32931600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024322A NO333664B1 (no) 2000-03-11 2002-09-10 Aminosyresekvens, nukleinsyresekvens fra HSP 70 antigenet til Piscirickettsia salmonis samt anvendelse av aminosyresekvens for vaksine- og kitfremstilling, vaksine og diagnostisk test-kit

Country Status (7)

Country Link
US (1) US6887989B2 (no)
EP (1) EP1282710B1 (no)
AU (1) AU2001240791A1 (no)
CA (2) CA2402718C (no)
DK (1) DK176903B1 (no)
NO (1) NO333664B1 (no)
WO (1) WO2001068865A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2381708C (en) * 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
ATE473236T1 (de) * 2003-10-07 2010-07-15 Michel Thiry Antigene von piscirickettsia salmonis und deren verwendung
AU2005291622A1 (en) * 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
US20110171251A1 (en) * 2004-10-01 2011-07-14 Micael Thiry Piscirickettsia salmonis antigens and use thereof
WO2008077413A1 (es) 2006-12-22 2008-07-03 Soluciones Biotecnologicas Innovacion Ltda Vacunas adn en peces
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
EP2482825B1 (en) 2009-10-02 2016-11-23 The Trustees of Columbia University in the City of New York Piscine reovirus diagnostic compositions
WO2013084169A2 (en) * 2011-12-07 2013-06-13 Yanez Carcamo Alejandro Javier Novel broth medium and blood-free solid media for the culture of the fish pathogen piscirickettsia salmonis
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO329958B1 (no) 1999-09-17 2011-01-31 Pfizer Canada Inc Anvendelse av en immunogen mengde av OspA-lipoprotein fra Piscirickettsia salmonis, OspA-antigen, og immunogene promiskuose TCE i et OspA-kimaert fusjonsprotein, for fremstilling av medikamenter, og immunologisk in vitro-fremgangsmate for deteksjon av humoralt antistoff mot OspA eller P. salmonis.
US20030165526A1 (en) 1999-09-17 2003-09-04 Kuzyk Michael A. Vaccines and agents for inducing immunity against rickettsial diseases, and associated preventative therapy
CA2381708C (en) 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis

Also Published As

Publication number Publication date
CA2407301A1 (en) 2004-03-18
NO20024322L (no) 2002-09-10
US20030138446A1 (en) 2003-07-24
CA2407301C (en) 2013-08-20
EP1282710B1 (en) 2008-03-05
EP1282710A2 (en) 2003-02-12
CA2402718A1 (en) 2001-09-20
DK176903B1 (da) 2010-04-06
NO333664B1 (no) 2013-08-05
WO2001068865A3 (en) 2002-03-07
US6887989B2 (en) 2005-05-03
DK200201270A (da) 2003-02-03
AU2001240791A1 (en) 2001-09-24
CA2402718C (en) 2013-06-25
WO2001068865A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
DE60013305D1 (de) Perkolationsvorrichtung
DE60140253D1 (de) Oreinheit
ATE290000T1 (de) Muscarinagonisten
ATE252099T1 (de) Biarylcarboxamide
NO20010834D0 (no) Flerbruks-rørfrakoblingsanordning
DE10136334B8 (de) Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de) Thiazinoxazolidinon
ATA2932001A (de) Schneefräse
DE60128494D1 (de) Wachstumhormonsekretionsförderer
ATE262530T1 (de) Indolochinazolinone
ATE298751T1 (de) 7-oxopyridoryrimidine
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de) Sulfonylguanidine
DE10196064T1 (de) Halbleiterfotodektionsgerät
NO20024322L (no) Sekvens
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
AR027931A1 (es) Antitranspirantes
DE10052925B4 (de) Schaukelbett
ATE476423T1 (de) Benzoylpyridazine
DE10085445T1 (de) Drahterodierbearbeitungseinrichtung
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
DE60107332D1 (de) Kraftstoffeinpritzventil
ATE284887T1 (de) Thienopyrrolidinone
DE10054120B4 (de) Aufsparrendämmelement

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NOVARTIS TIERGESUNDHEIT AG, CH

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ELANCO TIERGESUNDHEIT AG, CH

MM1K Lapsed by not paying the annual fees